| Revision as of 21:37, 19 April 2007 editJohner (talk | contribs)1,242 editsNo edit summary← Previous edit | Revision as of 19:32, 23 May 2007 edit undo89.243.219.131 (talk) ←Replaced page with 'A load of rubbish'Next edit → | ||
| Line 1: | Line 1: | ||
| A load of rubbish | |||
| '''Noradrenergic and specific serotonergic antidepressants''' (abbreviated: '''NaSSAs''') are a relatively new class of ]s.<ref>{{cite journal |author=Kent J |title=SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression |journal=Lancet |volume=355 |issue=9207 |pages=911-8 |year=2000 |pmid=10752718}}</ref> They are thought to work by blocking presynaptic alpha-2 ] that normally inhibit the release of the ]s ] (]) and ]. This results in increases in both noradrenergic and specific serotonergic transmission. | |||
| Examples of NaSSAs include: | |||
| * ] (Remeron®, Zispin®, Avanza®, Norset®, Remergil®) | |||
| NaSSAs are said to have fewer side effects than ]s and ]s (SSRIs) while being equally effective. In particular, it is said that the sexual dysfunction that is a relatively common side effect of SSRIs occurs significantly less often during treatment with Mirtazapine.<ref>{{cite journal |author=Fawcett J, Barkin R |title=Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression |journal=J Affect Disord |volume=51 |issue=3 |pages=267-85 |year=1998 |pmid=10333982}} </ref> | |||
| ==See also== | |||
| * ] | |||
| ==References== | |||
| <references/> | |||
| ] | |||
| ] | |||
| {{treatment-stub}} | |||
| {{Antidepressants}} | |||
Revision as of 19:32, 23 May 2007
A load of rubbish